This protocol applies to patients with known Protein C deficiency who also have a family history of venous thromboembolism and are currently exposed to a minor provoking risk factor for VTE.
The minor provoking risk factors in this scenario include transient immobility, minor injury, intercurrent illness, or infection — short-lived exposures that elevate VTE risk in this high-risk thrombophilia population.
Because family history of VTE is present alongside a confirmed high-risk thrombophilia, testing for the known familial thrombophilia is also a relevant consideration in this clinical context.
The approach in this setting involves thromboprophylaxis timed to the period of elevated risk — the complete structured regimen is available via the protocol below.
DOI: 10.1111/jth.15732
For individuals with a family history of VTE and known antithrombin, protein C, or protein S deficiency (high-risk thrombophilia) who have a minor provoking risk factor for VTE, the ASH guideline panel suggests testing for the known familial thrombophilia.
The panel suggests thromboprophylaxis in individuals with thrombophilia and no thromboprophylaxis in individuals without thrombophilia.
View source ↗